PET/MR Characterization of Renal Cell Carcinomas
Quantitative PET-MRI Imaging Correlated With Transcriptome Analysis for Noninvasive Characterization of Renal Cell Carcinomas
Sponsor: UNC Lineberger Comprehensive Cancer Center
Terminated
Funding insufficiency.
Other terminated trials from UNC Lineberger Comprehensive Cancer Center
- Prostate Cancer · Phase PHASE2 · Oct 2024
- Leukemia, Myeloid, Acute · May 2024
- Hematological Disorder · Phase NA · Sep 2023
- Bladder Cancer · Phase NA · Sep 2021
- Graft Vs Host Disease · Phase EARLY_PHASE1 · Mar 2020
See all terminations from UNC Lineberger Comprehensive Cancer Center
Other Renal Cell Carcinoma trials with similar outcome
A NA clinical study on Renal Cell Carcinoma, this trial is terminated or withdrawn. The trial is conducted by UNC Lineberger Comprehensive Cancer Center and has accumulated 10 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2023 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jul 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Jul 2023 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Nov 2021 — Nov 2022 [monthly]
Recruiting NA
-
Mar 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- UNC Lineberger Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .